This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Deepak Khatry Presents on Biomedicine Design at 2021 Festival of Biologics
March 16, 2021
Deepak Khatry, Ph.D., will be presenting at the 2021 Festival of Biologics, which is being held virtually March 29-April 1, 2021. The Festival is the meeting place for the life science community to bridge the gap between academia and industry. Westat is proud to be a sponsor and will be exhibiting at the event.
Dr. Khatry will be presenting Implications of Designs in Biomedicine and Clinical Trials: A Case Study of Currently Marketed Anti-IL5 Biologics at 12 noon (ET) on Thursday, April 1, 2021. His presentation will cover:
- A discussion on study design considerations that go beyond study success as defined by a statistically significant primary outcome
- A case study of 3 anti-eosinophilic currently marketed biologics (mepolizumab, reslizumab, and benralizumab) for treating severe asthma
- A presentation on Westat’s expertise and capability in partnering with and assisting early biotech, established biopharma, and other institutions working to discover, develop, and market small molecule drugs, biologics, and diagnostics
Featured Expert
Deepak B. Khatry
Associate Director